Abstract:Understanding molecular level interactions between the metabolome and proteome, two of the most important classes of molecules in biology, will generate deeper insight into the function of metabolites (natural products) which have a central role in interactions with therapeutic targets. Drug discovery in today’s pharmaceutical environment is driven by high-throughput screening of large chemical libraries. It is now 10 years since we published a paper on the development of natural product fraction libraries with control of LogP properties. We have now turned our attention to using pure natural product libraries to address the timeframe issues associated with isolation and characterization of the active constituent(s). Native mass spectrometry can be used as a robust platform for identifying the interactions between natural products and their protein targets. The recent development of Collision-Induced Affinity Selection mass spectrometry, a technique using capture of ligand-protein complexes followed by collision induced dissociation to identify library hits followed by direct ligand-protein confirmation in native mass spectrometry also enables screening of a greater proportion of human proteins. We will review native mass spectrometry-based approaches to use natural product extracts, pre-fractionated natural product libraries and pure natural product libraries for screening against molecular targets. We will also discuss some of the other mass-spectrometry based applications that have been implicated in natural product drug discovery.

Research Progress in Receptor Binding Assay by Mass Spectrometry

Micromechanical measurement of membrane receptor binding for label-free drug discovery.

Recent Advances in the Quantitative Determination of Protein Receptor–Ligand Interaction Kinetics

Advances in receptor chromatography for drug discovery and drug-receptor interaction studies

Biochemical applications of mass spectrometry in pharmaceutical drug discovery

Method to Screen Aromatic Ligands in Mixtures for Quantitative Affinities to Target Using Magnetic Separation of Bound Ligands along with HPLC and UV Photometry Detection

Radioligand Saturation Binding for Quantitative Analysis of Ligand-Receptor Interactions

Label-Free Quantification of Molecular Interaction in Live Red Blood Cells by Tracking Nanometer Scale Membrane Fluctuations.

LABEL‐FREE BIO‐AFFINITY MASS SPECTROMETRY FOR SCREENING AND LOCATING BIOACTIVE MOLECULES

Conventional Receptor Radioligand Binding Techniques Applied to the Study of Monoamine Oxidase

A New Method to Discover High-Affinity Ligands for Bio-Macromolecules:SAR-by-NMR

An Efficient and Label-Free LC-MS/MS Method for Assessing Drug's Activity at Dopamine and Serotonin Transporters Using Transporter-Transfected HEK293T Cells.

Metabolite-protein interactions: Native mass spectrometry and collision induced affinity selection mass spectrometry in natural product screening

Emerging affinity methods for protein-drug interaction analysis

Reversibly Reactive Affinity Selection-Mass Spectrometry Enables Identification of Covalent Peptide Binders

Pharmaceutical applications of affinity-ultrafiltration mass spectrometry: Recent advances and future prospects

Progress of Scintillation Proximity Assay in Life Science

Biomineralized Nuclear Receptor Protein-Selection Mass Spectrometry for the Discovery of Drugs and Toxics

Estimation of Binding Constants of Receptors and Ligands by Affinity Capillary Electrophoresis.

High-Throughput Native Mass Spectrometry Screening in Drug Discovery

In Situ and Label-Free Quantification of Membrane Protein–Ligand Interactions Using Optical Imaging Techniques: A Review